-
Real-World Relugolix Adherence Rates Are High in Patients on Medicare With Prostate Cancer
17 Feb 2025 18:03 GMT
… MD, FASCO, medical oncologist, UC San Diego Health, and professor, … Calithera Biosciences, Caris Life Sciences, Dendreon, Esiai, Exelixis, Janssen, Lilly … Sorrento Therapeutics, Sumitomo Pharma Oncology, Telix Pharmaceuticals, Tempus, and Vividion …
-
Hormone Sensitive Advanced Prostate Cancer Treatment Market 2032: FDA Approvals, Clinical Trials, drugs by DelveInsight
08 Jan 2025 12:39 GMT
… Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers, Dendreon Corporation … Advanced Prostate Cancer Drugs Uptake and Pipeline … Cancer Current Treatment and Medical Practices
10. Hormone … DelveInsight is a leading Healthcare Business Consultant, and …
-
Drug and Gene Delivery Devices Market CAGR of 11.6% Share, Trends, Growth And Forecast By 2024 To 2031 | Pfizer, Inc.
10 Dec 2024 14:45 GMT
… Human Stem Cell Institute
• Dendreon Pharmaceuticals
• Helixmith Co.
• … Drugs: Luxturna (Drug Delivery Devices), Yescarta (Drug Delivery Devices), Zolgensma (Drug Delivery Devices), Kymriah (Drug … and technology, healthcare, chemical and materials …
-
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
13 Nov 2024 13:00 GMT
… publicly traded biotechnology companies including Dendreon and Amgen. Ms. Eastland … has worked in the global pharmaceutical and medical technology industries for nearly … in Germany. About Zentalis Pharmaceuticals
Zentalis® Pharmaceuticals, Inc. is a clinical …
-
Chinese pharma companies eyeing strong foothold in therapeutic cancer vaccines market
26 Aug 2024 06:58 GMT
… and liver cancers.
Jithendra Kancharla, Pharma Analyst, GlobalData, commented, “Therapeutic … T (Provenge), developed by Dendreon Pharmaceuticals, for the treatment of advanced … FDA-approved therapeutic cancer vaccine.
According to GlobalData’s Pharmaceutical …
-
Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent prostate cancer
22 Aug 2024 15:55 GMT
… is androgen deprivation therapy — medication to stop testosterone production. However … .
Olaparib, a precision oncology drug which blocks the ability of … honoraria from Tempus, Dendreon, ObsEva, Astellas, MashupMD and Community Health Marketing, and grant …
-
Cell Therapy Market Shows Robust Growth Amid Rising Demand for Advanced Medical Solutions
01 Jul 2024 12:29 GMT
… , with initiatives like the FDA's push for … by increasing healthcare expenditure and rising awareness of advanced medical treatments.
… Inc.
Takeda Pharmaceutical Company Limited
bluebird bio, Inc.
Dendreon Pharmaceuticals LLC.
Thermo …
-
Data breach at pharma partner Cencora puts sensitive patient information at risk
28 May 2024 23:38 GMT
… with patients on medicines from a dozen drugmakers potentially affected.
Cencora … , Novartis, Regeneron, Incyte, Dendreon Pharmaceuticals, Sumitomo Pharma, Endo and GSK.
The … last names, addresses, birthdates, health diagnoses and prescriptions, Cencora …
-
Data breach at medical giant Cencora exposes info from multiple drug companies" data-before-rewrite-localise="/pro/security/data-breach-at-medical-giant-cencora-exposes-info-from-multiple-drug-companies
27 May 2024 16:06 GMT
… down from pharma giant Cencora.
In late February 2024, drug wholesale company … Pharmaceuticals, and Dendreon Pharmaceuticals.
The companies lost customers’ full names, postal addresses, health diagnoses, medications …
-
WestGene wins FDA nod to study mRNA vaccine to treat certain cancers
10 May 2024 20:00 GMT
The US Food and Drug Administration (FDA) has approved an IND to … therapies.
In 2010, the FDA approved Dendreon Pharmaceutical’s prostate cancer prophylactic Provenge … wide range of conditions.
Some pharmaceutical companies are using the mRNA …
About
© 1995-2025